Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing therapies for unmet medical needs, including treatments for cancer-related skin toxicities, mast cell cancers, neuroinflammatory diseases, eczema, asthma, allergies, and obesity. It leverages proprietary formulations, licensing agreements, and innovative drug platforms to address significant health conditions, relying on third-party manufacturing and regulatory approval processes to bring its products to market.
This description was generated via AI from an annual report. Updated about 1 year ago.